MedPath

The Effect of Obesity on Endometrium in PCOS

Completed
Conditions
Body Weight
Polycystic Ovary Syndrome
Interventions
Device: Doppler evaluation
Registration Number
NCT02694419
Lead Sponsor
Assiut University
Brief Summary

The effect of Polycystic Ovary Syndrome (PCOS) with or without obesity has received a few attentions. There is a lack of evidence to whether the BMI affects the endometrial blood flow, which is necessary for implantation.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
100
Inclusion Criteria
  • Women with PCOS are diagnosed according to Rotterdam criteria, (Rotterdam and ASRM-Sponsored, 2004)by the presence of two out of the following three: oligomenorrhea (absence of menses for 35-182 days) or amenorrhea (absence of menses for >182 days), signs or symptoms of hyperandrogenism (acne, hirsutism), US showing polycystic ovaries.
  • Fertile women had regular menstruation, with at least one previous spontaneous pregnancy.
Exclusion Criteria
  • Women known to have hepatic or renal dysfunction, Diabetes mellitus, hypertension, or cardiovascular disease.
  • If they have used induction of ovulation drugs for the last three months.
  • If they have used hormonal contraception in the last three months.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
normal weight/fertileDoppler evaluationFertile regularly menstruating women with at least one previous spontaneous pregnancy who are normal weight with BMI \< 25 kg/m2.
Obese/fertileDoppler evaluationFertile regularly menstruating women with at least one previous spontaneous pregnancy who are overweight\\obese with BMI ≥ 25 kg/m2.
obese/PCODoppler evaluationWomen with PCOS who are overweight\\obese with BMI ≥ 25 kg/m2.
normal weight/PCODoppler evaluationWomen with PCOS who are normal weight with BMI \< 25 kg/m2.
Primary Outcome Measures
NameTimeMethod
the mean difference in Doppler indices (VI-FI-VFI)24 hours
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Ahmed Abbas

🇪🇬

Assiut, Cairo, Egypt

© Copyright 2025. All Rights Reserved by MedPath